Eczema and Blood Sugar: Why Flares Worsen with High Glucose

If you have both diabetes and eczema (atopic dermatitis), you may have noticed that your skin tends to flare more severely during periods when your blood sugar is poorly controlled. This is not a coincidence — elevated glucose actively worsens the inflammatory and structural problems that drive eczema, while eczema's own inflammatory process creates metabolic stress that can disrupt blood sugar regulation in return. Understanding the eczema-blood sugar relationship is essential for managing both conditions effectively, and for Indian diabetics who face the additional challenges of a hot and humid climate, the stakes are even higher.

Understanding Eczema: A Skin Barrier and Immune Problem

Atopic dermatitis (eczema) is characterised by a combination of two fundamental defects: an impaired skin barrier and an overactive immune response, particularly of the Th2 pathway. The skin barrier in eczema patients is structurally deficient — mutations in the filaggrin gene (which produces a protein essential for assembling the stratum corneum's tight junction network) lead to a "leaky" skin barrier that allows allergens, irritants, and microbes to penetrate and escape moisture. The resulting immune activation creates a cycle of inflammation, itching, scratching, and further barrier damage.

Eczema is common globally and in India, where estimated prevalence is 2–8% depending on region and age group. It is particularly prevalent among children but can persist into adulthood — a pattern that is increasing with urbanisation, changing hygiene practices, and rising pollution levels in Indian cities. The combination of air pollution (high in cities like Delhi, Mumbai, and Kolkata), hard water, heat, humidity, and common dietary allergens makes India's environment particularly challenging for eczema management.

How High Blood Sugar Makes Eczema Worse: The Mechanisms

Several interacting mechanisms explain why hyperglycaemia exacerbates eczema:

Barrier dysfunction amplified: As discussed in the context of other diabetic skin conditions, chronic high blood glucose impairs the synthesis of ceramides and other lipids that form the skin barrier. In eczema, the barrier is already compromised by filaggrin deficiency and inflammation. When diabetes is added, both the lipid and protein components of the barrier are simultaneously impaired, creating skin that is far more permeable than either condition alone would produce. The result is dramatically increased transepidermal water loss (TEWL), which explains why diabetic skin with eczema feels so intensely dry and tight.

Immune polarisation toward Th2: Both atopic dermatitis and poorly controlled diabetes involve dysregulation of immune responses. Hyperglycaemia has been shown to shift immune responses toward Th2 dominance — the same immune pathway that drives eczema. Elevated glucose promotes IL-4 and IL-13 production, cytokines that are central to eczematous inflammation. This immune environment creates conditions that favour eczema flares.

Microbiome disruption: The skin microbiome — the community of bacteria, fungi, and other microorganisms living on skin — plays a critical role in eczema. Staphylococcus aureus colonisation of eczematous skin is almost universal during flares; staph secretes toxins and proteases that directly damage the skin barrier and activate inflammatory pathways. High glucose on the skin surface (from sweat and transepidermal glucose) creates a more nutrient-rich environment for pathogens including staph, facilitating heavier colonisation. In diabetics, the impaired innate immune response (reduced neutrophil function, lower antimicrobial peptide production) further tips the balance toward bacterial overgrowth and eczema exacerbation.

Nerve-skin axis disruption: Diabetic neuropathy affects small nerve fibres in the skin, disrupting the normal neurogenic regulation of inflammation and the release of neuropeptides like substance P that maintain skin homeostasis. This nerve-skin axis dysregulation may contribute to abnormal inflammatory responses and altered itch signalling in eczema.

Recognising an Eczema Flare in Diabetic Skin: What to Look For

Eczema can present across the full spectrum of severity, and distinguishing an eczema flare from other diabetic skin conditions is important for appropriate management. Classic eczema features include: intensely itchy, red, weeping, or crusted patches (in acute flares); thickened, leathery, hyperpigmented skin (lichenification) from chronic scratching; dry, scaly patches in the antecubital fossa (inner elbow), popliteal fossa (behind the knee), neck, and wrists — the classic eczema distribution in adults; and bilateral, often symmetric distribution.

In Indian skin tones, the classic "erythematous" (red) description may be misleading — eczema in darker skin more commonly appears as darkened, brownish, or greyish patches, and the papular (raised bumps) component may be more prominent than the redness. Post-inflammatory hyperpigmentation — the dark marks left after an eczema flare resolves — is a major cosmetic concern for Indian patients and can persist for months after the inflammation has cleared.

Warning signs that a flare may be infected (requiring antibiotic treatment beyond standard eczema care): golden crusting or oozing, rapidly worsening areas despite treatment, fever, swollen lymph nodes, and failure to respond to topical steroids within a week. In diabetics, infected eczema can progress quickly to cellulitis, so early medical review is warranted.

Treating Eczema in Diabetics: What Works and What to Watch

Managing eczema in a person with diabetes requires attention to the specific concerns that diabetes creates for standard eczema therapies. The cornerstone of eczema treatment — moisturising and topical corticosteroids — applies, but with modifications:

Moisturising: This is the most important intervention and the one with the fewest risks. Apply thick, ceramide-containing emollients multiple times daily — at minimum morning and evening, and immediately after every wash. Consistency is more important than the specific product chosen. Ointments and creams are more effective than thin lotions for eczema. Applying moisturiser within 3 minutes of bathing ("soak and seal" method) locks in moisture most effectively. Movataa's body care products, designed for diabetic skin with a ceramide-rich, fragrance-free formulation, are well-suited for eczematous diabetic skin — explore at /collections/body-care. Fragrance must be completely avoided in eczema patients as it is a common sensitiser and irritant.

Topical corticosteroids: Appropriate for flares, using the lowest potency that achieves control. In diabetics, use potent steroids judiciously and avoid extensive, prolonged use or application under occlusion to prevent systemic glucose effects. Topical calcineurin inhibitors (tacrolimus and pimecrolimus) are excellent steroid-sparing options with no glucose-elevating effect — they are preferred for maintenance therapy in sensitive areas (face, skin folds) and for long-term flare prevention in diabetics.

Dupilumab: This biologic targeting IL-4Rα (blocking both IL-4 and IL-13) has transformed eczema management for moderate-severe cases and is metabolically neutral — making it an excellent option for diabetics with significant eczema. It is increasingly available in India through dermatology centres in major cities, though cost and access remain barriers.

Antihistamines: Sedating antihistamines (such as hydroxyzine or chlorpheniramine) are used for nighttime itch in eczema. They have no direct glucose effects, but sedation-related disruption of sleep architecture can affect insulin sensitivity in diabetics — use with awareness and avoid the morning-after sedation that disrupts daily glucose management routines.

Identifying Eczema Triggers in the Indian Diabetic Context

Preventing eczema flares requires identifying and avoiding personal triggers. For Indian diabetics, some particularly relevant triggers include: dietary allergens common in Indian cuisine (milk and dairy products, eggs, wheat, peanuts, sesame) — these are also insulin response-relevant foods, so an elimination trial with dietitian guidance can address both eczema and glucose management simultaneously; sweating and heat — India's humid climate causes sweat-induced eczema flares, particularly in skin folds; hard water (high mineral content) — common in many Indian cities and associated with eczema severity; synthetic fabrics and elastic in undergarments and sarees — friction and occlusion worsen eczema in skin folds; and stress — a bidirectional relationship exists where psychological stress worsens both eczema flares and blood glucose control, creating a harmful spiral that requires dual management. For guidance on managing stress in the context of diabetic skin, refer to Movataa's Diabetic Skincare Guide.